AQR Capital Management
GH icon

AQR Capital Management’s Guardant Health GH Stock Holding History

AQR Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
131,298
+32,425
+33% +$3.26M 0.01% 1246
2025
Q4 		$10.1M Buy
98,873
+17,296
+21% +$1.55M 0.01% 1212
2025
Q3 		$5.1M Buy
81,577
+1,446
+2% +$78.7K ﹤0.01% 1446
2025
Q2 		$4.17M Buy
80,131
+8,597
+12% +$384K ﹤0.01% 1386
2025
Q1 		$3.01M Buy
71,534
+25,831
+57% +$1.11M ﹤0.01% 1376
2024
Q4 		$1.4M Buy
45,703
+33,268
+268% +$936K ﹤0.01% 1711
2024
Q3 		$285K Buy
+12,435
New +$352K ﹤0.01% 2417
2024
Q1 		– Sell
-26,817
Closed -$725K – 2442
2023
Q4 		$725K Buy
26,817
+905
+3% +$23.7K ﹤0.01% 1726
2023
Q3 		$768K Sell
25,912
-64,567
-71% -$2.27M ﹤0.01% 1696
2023
Q2 		$3.24M Buy
+90,479
New +$2.6M 0.01% 1082
2023
Q1 		– Sell
-13,418
Closed -$351K – 2201
2022
Q4 		$351K Buy
+13,418
New +$614K ﹤0.01% 1925
2021
Q3 		– Sell
-22,351
Closed -$2.78M – 2268
2021
Q2 		$2.78M Sell
22,351
-2,740
-11% -$369K ﹤0.01% 1049
2021
Q1 		$3.73M Sell
25,091
-2,890
-10% -$437K 0.01% 899
2020
Q4 		$3.52M Sell
27,981
-11,129
-28% -$1.28M 0.01% 899
2020
Q3 		$4.35M Buy
39,110
+143
+0.4% +$13.1K 0.01% 812
2020
Q2 		$3.11M Buy
38,967
+15,927
+69% +$1.28M 0.01% 966
2020
Q1 		$1.6M Buy
+23,040
New +$1.77M ﹤0.01% 1155

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management's GH Position: Q1 2026 in Review

AQR Capital Management increased its Guardant Health (GH) stake by 33% in Q1 2026, buying an estimated $3.26M and bringing the position to 131,298 shares worth $12.1M. The position accounts for 0.01% of the portfolio, ranked #1246.

AQR Capital Management first reported a position in GH in Q1 2020 and has held it in 17 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • AQR Capital Management held 131,298 shares of Guardant Health worth $12.1M as of Q1 2026.
  • AQR Capital Management bought 32,425 Guardant Health shares in Q1 2026, an estimated $3.26M.
  • Guardant Health made up 0.01% of AQR Capital Management's portfolio in Q1 2026, its #1246 holding.
  • AQR Capital Management first reported a position in Guardant Health in Q1 2020 and has held it in 17 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.